Antiviral treatment of SARS: Can we draw any conclusions?

Zhaori, Getu
November 2003
CMAJ: Canadian Medical Association Journal;11/25/2003, Vol. 169 Issue 11, p1165
Academic Journal
Presents opinion on the antiviral therapy of severe acute respiratory syndrome (SARS). Experience with empirical treatment of SARS with ribavirin; Regimens that could be used or another outbreak of SARS.


Related Articles

  • Recent Developments in the Virology and Antiviral Research of Severe Acute Respiratory Syndrome Coronavirus. Kap-Sun Yeung; Meanwell, Nicholas A. // Infectious Disorders - Drug Targets;Mar2007, Vol. 7 Issue 1, p29 

    This article summarizes the significant developments and new discoveries in both the virology and antiviral research associated with the severe acute respiratory syndrome coronavirus (SARS CoV) that were reported in 2005 and 2006. Areas reviewed include genomic studies and the identification of...

  • Anti-infectives: Targeting SARS. Jones, Susan // Nature Reviews Microbiology;Sep2004, Vol. 2 Issue 9, p686 

    The article reports developments on the study on severe acute respiratory virus (SARS-CoV) as published in the Proceedings of the National Academy of Sciences in the U.S. Based on the report, fifteen compounds that are potent against the SARS-CoV were identified. They include the ribavirin and...

  • The Treatment of SARS A Comparison of Western and TCM Methods. Li, Shunyu; Wang, Mina // Oriental Medicine Journal;Aug2004, Vol. 12 Issue 5, p18 

    The article presents information on the western and TCM methods used in the treatment of SARS. The mainstream therapeutic interventions for SARS involve broad-spectrum antibiotics and supportive care, as well as antiviral agents and immunomodulatory therapy. Anti-bacterial agents are routinely...

  • SARS: Understanding the Virus and Development of Rational Therapy. Stadler, K.; Rappuoli, R. // Current Molecular Medicine;Nov2005, Vol. 5 Issue 7, p677 

    In late 2002 a new disease, severe atypical respiratory syndrome (SARS), emerged in China. A hitherto unknown animal coronavirus (CoV) that had crossed the species barrier through close contact of humans with infected animals was identified as the etiological agent. It rapidly adapted to the new...

  • Integrating Newly Discovered Anti-Viral Herbs with Classical Wen Bing Theory. Fratkin, Jake // Oriental Medicine;2005, p418 

    Several charts on the classical Wen Bing theory and the response of traditional Chinese medicine to the SARS epidemic, 2003 are presented.

  • Antiviral agents and corticosteroids in the treatment of severe acute respiratory syndrome (SARS). Yu, W. C.; Hui, D. S. C.; Chan-Yeung, M. // Thorax;Aug2004, Vol. 59 Issue 8, p643 

    The epidemic of severe acute respiratory syndrome (SARS) of 2003 caught the medical profession by surprise. The accumulated global total caught the medical profession by number of cases was 8098 with 774 deaths, a case-fatality ratio of 9.6%. Although the novel coronavirus was discovered within...

  • Current Advances in Anti-Influenza Therapy. Saladino, R.; Barontini, M.; Crucianelli, M.; Nencioni, L.; Sgarbanti, R.; Palamara, A. T. // Current Medicinal Chemistry;Jul2010, Vol. 17 Issue 20, p2101 

    Every year, influenza epidemics cause numerous deaths and millions of hospitalizations, but the most frightening effects are seen when new strains of the virus emerge from different species (e.g. the swine-origin influenza A/H1N1 virus), causing world-wide outbreaks of infection. Several...

  • Ribavirin for SARS in Children. Wai Tsoi Frankie Cheng, Valerie; Li, Chi Kong; Leung, Ting Fan; Albert Man-chim Li, Valerie; Kam Lun Ellis Hon, Valerie; Pak Cheung Ng, Valerie; Tai Fak Fok, Valerie // Clinical Pediatrics;Mar2004, Vol. 43 Issue 2, p193 

    Investigates the effectiveness of ribavirin for the treatment of SARS in children. Median pretreatment hemoglobin level; Mechanism of action of the drug; Absence of any clinically significant adverse effects associated with high dose of oral and intravenous ribavirin treatment.

  • Clinical Trials and Novel Pathogens: Lessons Learned from SARS. Muller, Matthew P.; McGeer, Allison; Straus, Sharon E.; Hawryluck, Laura; Gold, Wayne L. // Emerging Infectious Diseases;Mar2004, Vol. 10 Issue 3, p389 

    During the recent global outbreak of severe acute respiratory syndrome (SARS), thousands of patients received treatments such as ribavirin and corticosteroids. Despite this, no controlled clinical trials assessing the efficacy of these agents were conducted. If a second global SARS outbreak...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics